Synthesis and radioiodination of a stannyl oligodeoxyribonucleotide were undertaken to evaluate a gamma ray emitting ODN ligand for thrombus imaging in vivo. Synthesis of the ODN was based on modified automated β-cyanoethyl phosphoramidite chemistry with an organotin nucleoside (dU*) coupled to a thrombin binding aptamer sequence to give d(U*GGTTGGTGTGGTTGG). The synthesis accommodated dU*, which is destannylated by iodine or acids. Fourteen standard synthesis cycles were followed by one 'stannyl synthesis cycle', distinguished by 
INTRODUCTION
We wish to label the aptamer sequence d(GGTTGGTGTGGTT-GG) with a gamma emitting radioiodine, and evaluate it as a thrombus imaging radiotracer. The aptamer was selected by combinatorial chemistry for binding to human thrombin (K d = 20 nmol) (1) . The aptamer assumes a triple loop structure with two guanine quartets in solution; it functions in animal serum as an anticoagulant (2) . The radioiodines permit labeling DNA with diverse gamma emitters ( 123 I and 131 I; SPECT imaging) and positron emitters ( 124 I; PET imaging). Direct radioiodination of pyrimidine nucleosides at C5 is feasible, but it is unsatisfactory for polymeric DNA. In situ metallation/iodination with thallium (3) or mercury (4) can facilitate carrier-added radioiodination of DNA. A stable organotin precursor would improve the radioiodination of DNA. Vinyl and aromatic organotin compounds are highly reactive to no-carrier-added iododestannylation (5, 6) . Organotin compounds also possess notable hydrophobicity, so that a high specific activity iodo product is readily separated from the precursor. Organotin precursors are valuable for the preparation of radioiodine pharmaceuticals. We seek to incorporate an organotin analog of 2′-deoxyuridine (dU*) to obtain the sequence d(U*GGTTGGTGTGGTTGG), and then to radioiodinate the organotin sequence. The nucleoside of choice is IVDU (and its organotin analog). IVDU is an antiherpes nucleoside (7) and radiotracer (8, 9 ) dependent on herpesvirus thymidine kinase (10) , that does not enter the DNA of uninfected cells (11) . An applicable organotin nucleoside synthesis is available (12) . Accessible automated β-cyanoethyl phosphoramidite DNA synthesis is the technology of choice (13, 14) . However the iodine and acidic reagents of the standard synthesis cycle will destannylate the organotin nucleoside residue prematurely. The available chemistries require modification for efficient synthesis of organotin DNA, consequently permitting organotin DNA to be evaluated as a precursor for radiohalogenated DNA pharmaceuticals.
MATERIALS AND METHODS
[ 123 I]NaI in 0.1 N NaOH was obtained from Nordion International. Gamma rays were detected with a well type NaI detector (Beckman), a dosimeter (Capintec) or (for HPLC effluent) a sodium iodide crystal (Bicron, 2 in) detector supported by Ortec amplifier (490B), ratemeter (541) and power supply (478) modules. The NMR Laboratory of the University of British Columbia (UBC) utilized a 200 MHz Bruker AC-200 ( 1 H-NMR) or a 300 MHz Varian XL-300 ( 31 P-NMR) for our specimens. Elemental analysis was performed by the UBC Microanalytical Chemistry Laboratory. The UBC Mass Spectroscopy Laboratory performed Desorption Chemical Ionization (DCI) mass spectroscopy in the positive ion mode with methane gas in the Delsi Nermag R10-10 C. Inductively coupled plasma mass spectroscopy (ICPMS) analysis of tin was performed by Elemental Research Inc. of North Vancouver, BC. ODNs were resolved by reverse phase HPLC (C18, 5 µm, 4 mm × 250 mm; Pharmacia P/N: 80-1266-38; or Phenomenex P/N: 00G-4097-E0) with CH 3 CN 10-50% (42 min) 
5′-[fluorenylmethoxycarbonyl]-5-iodo-2′-deoxyuridine (2)
The standard Fmoc derivitization procedure was used (16) 
Preparation of 5′-[fluorenylmethoxycarbonyl]-5-(E)-[2-tri-n-butylstannylvinyl]-2′-deoxyuridine (3)
Protected nucleoside 2 [403 mg, 0.7 mmol, twice evaporated from dry acetonitrile (10 ml) with dry toluene (5 ml)] was suspended with (E)-1,2-bis(tri-n-butylstannyl)ethene (17) (750 mg, 1.24 mmol), bis(triphenylphosphine) palladium (II) chloride (27 mg, 38 µmol), acetonitrile (10 ml) and toluene (5 ml). The mixture was divided between two 10 ml serum vials which were sealed, flushed with nitrogen, and heated at 80_C with magnetic stirring. A black precipitate appeared abruptly at 18 min; the mixture was stored at -20_C. The consumption of 2 was complete as judged by TLC (toluene/CH 3 CN; 1/1). The reaction mixture was purified twice by flash column chromatography on a short SiO 2 column (4.5 cm × 4 cm; methylene chloride/ethyl acetate; 1/1). The colourless oil product was dissolved in CH 2 Cl 2 (1 ml) and dispersed in n-heptane (25 ml), where a flocculant white precipitate was obtained. An amorphous white solid product was recovered (135 mg, 25% yield). (3) was noted (R f = 0.13). A narrow band of 3′,3′-dinucleoside monophosphite was identified (R f = 0.26). 31 P-NMR (H 3 PO 4 standard) was performed with a 6 h product diluted in CH 3 CN/CD 3 CN (19, 20) .
Coupling of nucleoside phosphoramidite 5 to the 5′-hydroxyl of the aptamer oligonucleotide ODN synthesis was carried out on the Applied Biosystems 391 DNA synthesizer, on a 1 µmol scale. Fourteen rounds of standard synthesis cycle were used to prepare d(GGTTGGT-GTGGTTGG) (ODN 6) with the DMT-group removed but left on the support. The support was removed from the synthesizer and washed with acetonitrile (3 × 1.5 ml). To the solution of 5 was added tetrazole (0.45 M; 250 µl). The support was exposed to the activated 5 for 5 min total, with the help of a 5 ml syringe (21) , and washed again with acetonitrile (2 × 1.5 ml). Oxidation was carried out by treating the solid support for 30 s with 3-chloroperoxybenzoic acid (15,21) (0.1 M in methylene chloride containing 2% pyridine; 2 ml), followed by washing with acetonitrile (2 × 1.5 ml). The oligonucleotide was cleaved from the support by treating with ammonium hydroxide (35% in water) for 30 min at 20_C. Subsequent deprotection was carried out in two stages: first, the ODN solution was heated 10 min at 55_C in the same ammonium hydroxide; second, aqueous methylamine (22) was added to give 1:1 by volume [ammonium hydroxide (35% in water); methylamine (40% in water)]; the ODN was heated an additional 20 min at 55_C. ODN samples were then evaporated to dryness, resuspended in ammonium hydroxide (100 µl, 35%) and reprecipitated from n-butanol (23) . The product was purified by HPLC (TEAB). ODN concentration was estimated from the formula 25 OD 254 /mg DNA. ODN portions (200 µg) were brought to dryness in a vacuum centrifuge in the presence of TEA (10 µl per tube initially, and later 5 µl TEA). Pure ODN 7 was obtained, with <1% ODN 8 initially. Dried ODN 7 was stored in a refrigerator freezer at -20_C, where decomposition to ODN 8 amounted to ∼50% after 6 months.
Derivatives
Bromination. To ODN 7 (200 µg, 32 nmol) in chilled buffer (100 µl, pH 7.2; Na phosphate 0.05 M; NaCl 0.05 M) was added N-bromosuccinimide (17 µg in 17 µl methanol, 95 nmol). Following 5 min, the reaction mixture was purified by HPLC (TEAB) and ODN 11 was recovered by Speedvac.
Iodination. ODN 7 (200 µg, 32 nmol) was similarly suspended in water (100 µl) with N-iodosuccinimide (7 µg in 7 µl methanol, 32 nmol) for 5 min to give ODN 9.
Proton-destannylation. ODN 7 (1 mg) was suspended in HAc/H 2 O (80/20; 300 µl) at 20_C. After 20 min ethanol (300 µl) was added and ODN 8 was recovered under vacuum. The residue was extracted with H 2 O/Et 2 O (300 µl/ml) and dried a second time. Nucleoside compositions were determined using snake venom phosphodiesterase (SVDE) and alkaline phosphatase, following a literature procedure (24) .
Determination of aptamer affinity for thrombin
Human α-thrombin (Enzyme Research) was derivatized with fluorescein-labeled D-Phe-Pro-Ala-CH 2 Cl (PPACK) (Haematologic Technologies) blocking the active site (29) . Thrombin solution (20 mM Tris, 150 mM NaCl, pH 7.4) was titrated with aptamer. The fluoresence intensity was monitored using a Luminescence Spectrophotometer (LS50b; Perkin Elmer) ( 
Radioiodination
Radioiodinations were carried out in a fumehood, in miniature stoppered glass tubes. Literature procedures were performed with Chloramine T (100 µg) (12), Iodogen (10 µg) (25), Iodobead (26), lactoperoxidase/Sepharose (Worthington) (27) or peracetic acid (28) . (Table 2 ). Reactions utilized ODN 7 (100 µg) and [ 123 I]NaI (1 mCi). Samples (20 µl) were quenched at suitable times using Na 2 S 2 O 3 (100 µg in 100 µl H 2 O) and analyzed by HPLC. An illustrative description of larger scale radioiodination follows: ODN 7 (100 µg in 20 µl H 2 O) was suspended in sodium phosphate (150 µl; pH 7.0, 0.05 M) and [ 123 I]NaI (4.82 mCi; 8 µl; 0.1 M NaOH) with an Iodobead. Following 5 min, the reaction solution was quenched in water (160 µl) with Na 2 S 2 O 3 (10 µg). The product (3.87 mCi) was purified by HPLC (TEAB), and the ODN 9 fraction (3.20 mCi; 90% labeling yield) was recovered. A portion of the product (2.86 mCi) was divided among four plastic tubes and evaporated in a vacuum centrifuge. The recovered yield at 110 min was 2.53 mCi (52% uncorrected). The product was 98% ODN 9 with 2% inorganic iodide. One ODN portion was re-run on HPLC. The total ODN absorbance was estimated 4 × 6.48 × 10 -3 OD 254 , or 166 pmol, and the specific activity for 2.53 mCi was 15 000 Ci/mmol. Physiological solutions were formulated in potassium phosphate buffer (0.05 M, pH 7.0). 
RESULTS
An alternative 'stannyl synthesis cycle' was developed in order to accommodate the stannyl reactivity. An organotin nucleoside was prepared with base-cleavable fluorenylmethyl (Fmoc) protection. Scheme 1 illustrates how 5-iodo-2′-deoxyuridine (1) was treated with 9-fluorenylmethyl chloroformate/pyridine to give 5′-[fluorenylmethoxycarbonyl]-5-iodo-2′-deoxyuridine (2) (57%). Treatment of 2 with E-1,2,-bis(tri-(n-butyl)stannyl)ethene and a catalytic quantity of (Ph 3 P) 2 (31, 32) . The reaction required 5 h to reach completion. 31 P-NMR analysis identified the nucleoside diastereomers (148.6 and 149.0 p.p.m.) and phosphoramidous acid (14 p.p.m.). The 31 P peak of reagent 4 (124 p.p.m.) was not observed in the product solution (18) (19) (20) . The combined TLC/NMR observations led to the important inference that the tributylstannyl moiety of the nucleoside remained intact until it was incorporated into DNA.
The organotin nucleoside phosphoramidite (5) was coupled with DNA. First, d(GGTTGGTGTGGTTGG) (1 µmol) was prepared by 14 standard phosphoramidite synthesis cycles; the oligonucleotide was left attached to the CPG support. The stannyl synthesis cycle reactions were then carried out using syringe technique. The resin was dehydrated with dry CH 3 CN, and then treated with 5 (28 µmol) in the presence of tetrazole catalyst. The resin was washed (CH 3 CN), and the phosphite triester was oxidized with 3-chloroperoxybenzoic acid/methylene chloride/ pyridine, followed by washing with CH 3 CN. Initially, a standard workup in ammonium hydroxide (35%) was employed. Following cleavage (1 h at 20_C) and deprotection (17 h at 55_C), the solution was concentrated in a vacuum centrifuge. A final extraction with n-butanol, and drying under vacuum provided a white pellet.
HPLC of the product revealed the unmodified ODN 6 and two additional peaks, ODNs 7 (∼20%) and 8 (∼70%). Elemental tin mass cluster was identified (ICPMS) in ODN 7 and not in ODNs 6 or 8. Upon acetic acid treatment, ODN 7 was converted to ODN 8, while ODNs 6 and 8 were inert. Upon treatment with iodine/CH 3 CN, ODN 7 was converted to the new ODN 9, while ODNs 6 and 8 were inert. This led to the identification of ODN 7 as the organotin species and ODN 8 as the destannylated product as indicated in Table 1. ODN 7 was apparently destannylated during workup and HPLC. Increased yield of ODN 7 followed revised, briefer deprotection with a mixture of methylamine and ammonium hydroxide (1:1; 'AMA') (20 min at 55_C). ODN 7 remained intact during standard cleavage (1 h at 20_C in 35% ammonium hydroxide). Destannylations of 15-30% were obtained with the revised workup. A 'satellite' isomer of ODN 7 (∼20% of 7) appeared on HPLC following cleavage with methylamine or AMA. To suppress the new isomer, cleavage was always carried out in ammonium hydroxide. Deprotection was divided into two stages: a 10 min treatment with ammonium hydroxide was followed by a 20 min treatment with AMA. Standard evaporation in a vacuum centrifuge concluded the workup. Since ODN 7 was unstable in TEAA (with a half-life of ∼5 h), the HPLC was improved by adopting TEAB, leading to pure intact ODN 7.
Iodinated ODN 9 was prepared by treating ODN 7 with N-iodosuccinimide. Brominated ODN 11 was likewise prepared using N-bromosuccinimide. ODN 8 was prepared by treating ODN 7 with acetic acid. The nucleoside composition of the derived DNA molecules showed only the standard nucleosides dG and T and the appropriate vinyl nucleoside (BrVDU, IVDU or VDU) in the correct molar ratio (9:6:1; dG:T:vinyl nucleoside).
The binding and K d of ODNs 6 and 9 were determined with human α-thrombin. A fluorometric binding assay was based on a fluorescein-PPACK active-site-blocked derivative of human α thrombin (Fig. 1) . A K d of 36 nM was found for ODN 9, while a K d of 45 nM was found for ODN 6. No binding to thrombin was observed with the scrambled aptamer sequence, d(GGTGGTGG-TTGTGGT).
A preliminary radioiodination trial (with Chloramine T) demonstrated that purified ODN 7 substrate led to a pure ODN 9 product. Non-purified ODN 7 substrate led to numerous small 123 I peaks (in addition to ODN 9) following radioiodination. Subsequent trials were performed to determine whether ODN 7 is very accessible to diverse radioiodination reactions. Radioiodinations were carried out with pure ODN 7 (100 µg), [ 123 I]NaI (1 mCi), and five different oxidants. Table 2 lists the radioiodination yields. The N-chloro oxidants led to various quantities of ODN 10. Destannylated ODN 8 was found in all the reactions. Most ODN 8 originated from frozen ODN 7 samples. ODN 8 was elevated with peracetic acid. Some 123 I was bound to the lactoperoxidase matrix. The Iodobead mediated labeling yield was determined with different concentrations of ODN 7 (100 µg, 97%; 50 µg, 86%; 25 µg, 73%; 10 µg, 12%). Figure 2 illustrates HPLC resolution of the products at 1 and 5 min following the radioiodination of ODN 7 (100 µg) . The increase in ODN 10 (2.5 and 9.4%) can be seen. Roughly 1% of the unlabeled material trailed into the ODN 9 fraction. An illustrative 5 min reaction with 4.8 mCi [ 123 I]NaI gave 90% labeling. A portion was evaporated and provided 2.53 mCi product at 110 min (52% uncorrected yield). HPLC analysis indicated 98% ODN 9, 2% iodide, and specific activity 15 000 Ci/mmol.
DISCUSSION
Stannyl ODN 7 was obtained by the following strategy. Fourteen rounds of standard synthesis cycle were followed by a single round of 'stannyl synthesis cycle' distinguished by Fmoc protection, omission of capping, oxidation by an organic peroxide and cleavage by ammonium hydroxide. A mild workup utilized brief deprotection with methylamine and HPLC in triethylammonium bicarbonate/CH 3 CN. Methylamine (22) has recently been introduced for rapid deprotection (22, (33) (34) (35) . Standard dC bz is methylated in the presence of methylamine, so that inert N4-acetyl-deoxycytidine (dC ac ) must be used (22) .
The net result of the DNA synthesis operation is that one organotin nucleoside is located at the 5′ terminal of ODN 7. One (and no more) organotin site is desired for radioiodination. Multiple organotins would lead to multiple pharmaceutical products and leave residual organotin in the labeled ODN. The ODN synthesis is entirely non-radioactive and separate from the radioiodine procedure.
Nucleoside 5 was coupled with up to 93% efficiency; the minimum destannylation experienced was 15%, and the best yield of ODN 7 was 70% as judged by HPLC. The typical recovered yield following HPLC was 2.3 mg ODN 7 from a 1 µmol run, sufficient for 23 labelings at the 100 µg scale.
High radioiodination yields with five different oxidants proved that ODN 7 is accessible to diverse radioiodination reactions. Unlabeled by-products, particularly ODN 10 and ODN 8, limit the specific activity of the product. We obtained a product with specific activity 15 000 Ci/mmol, compared to the theoretical limit of 239 000 Ci/mmol for 123 I (half-life 13.2 h).
Excellent HPLC resolution is a key factor permitting high specific radioactivity ODN products to be obtained. ODNs (7) (8) (9) (10) (11) differing by even a single atom (H, I, Cl or Br) were resolved by reversed phase HPLC following halogenation of ODN 7. Several isomeric by-products were also identified and eliminated through HPLC. Several features of the chemistry are novel (especially organotin, halogens, vinyl nucleosides and the aptamer structure) and the HPLC resolution cannot be attributed to one single factor at present. The stannyl residue provided more retention than the widely used dimethoxytrityl (DMT) group on a comparable aptamer sequence (41 versus 29 min).
The biochemical K d for ODN 9 with α-thrombin (36 nM) was similar to the K d of ODN 6 (45 nM). This suggests that the aptamer consensus structure is effective in ODN 9, and that ODN 9 should be evaluated for thrombus imaging.
